147 related articles for article (PubMed ID: 11429035)
1. Famciclovir treatment of hepatitis B infection following liver transplantation: a long-term, multi-centre study.
Manns MP; Neuhaus P; Atkinson GF; Griffin KE; Barnass S; Vollmar J; Yeang Y; Young CL;
Transpl Infect Dis; 2001 Mar; 3(1):16-23. PubMed ID: 11429035
[TBL] [Abstract][Full Text] [Related]
2. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
[TBL] [Abstract][Full Text] [Related]
3. Famciclovir in chronic hepatitis B: results of a dose-finding study.
Trépo C; Jezek P; Atkinson G; Boon R; Young C
J Hepatol; 2000 Jun; 32(6):1011-8. PubMed ID: 10898322
[TBL] [Abstract][Full Text] [Related]
4. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results.
Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J
Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
[TBL] [Abstract][Full Text] [Related]
6. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
[TBL] [Abstract][Full Text] [Related]
7. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of famciclovir for recurrent or de novo hepatitis B virus infection after liver transplantation.
Rayes N; Seehofer D; Bechstein WO; Müller AR; Berg T; Neuhaus R; Neuhaus P
Clin Transplant; 1999 Dec; 13(6):447-52. PubMed ID: 10617232
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant famciclovir as prophylaxis for hepatitis B virus recurrence after liver transplantation.
Singh N; Gayowski T; Wannstedt CF; Wagener MM; Marino IR
Transplantation; 1997 May; 63(10):1415-9. PubMed ID: 9175803
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Kruger M; Böker KH; Zeidler H; Manns MP
J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lamivudine for the treatment of hepatitis B virus infection after liver transplantation in children.
Shapira R; Mor E; Bar-Nathan N; Sokal EM; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2001 Jul; 72(2):333-6. PubMed ID: 11477362
[TBL] [Abstract][Full Text] [Related]
12. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
[TBL] [Abstract][Full Text] [Related]
13. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
14. Current pharmacotherapy for the treatment of chronic hepatitis B.
Lagget M; Rizzetto M
Expert Opin Pharmacother; 2003 Oct; 4(10):1821-7. PubMed ID: 14521491
[TBL] [Abstract][Full Text] [Related]
15. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK
J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605
[TBL] [Abstract][Full Text] [Related]
16. Lamivudine and famciclovir combination therapy with or without addition of interferon-alpha-2b for HBeAg-positive chronic hepatitis B: a pilot study.
Sangfelt P; Uhnoo I; Hollander A; Lindh G; Weiland O
Scand J Infect Dis; 2002; 34(7):505-11. PubMed ID: 12195876
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B.
de Man RA; Marcellin P; Habal F; Desmond P; Wright T; Rose T; Jurewicz R; Young C
Hepatology; 2000 Aug; 32(2):413-7. PubMed ID: 10915751
[TBL] [Abstract][Full Text] [Related]
18. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
Ben-Ari Z; Mor E; Shapira Z; Tur-Kaspa R
Liver Transpl; 2001 Feb; 7(2):113-7. PubMed ID: 11172394
[TBL] [Abstract][Full Text] [Related]
19. Famciclovir treatment of chronic hepatitis B in heart transplant recipients: a prospective trial.
Wedemeyer H; Böker KH; Pethig K; Petzold DR; Flemming P; Tillmann HL; Vollmar J; Bastürk M; Goldmann E; Griffin KE; Haverich A; Manns MP
Transplantation; 1999 Nov; 68(10):1503-11. PubMed ID: 10589947
[TBL] [Abstract][Full Text] [Related]
20. Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Berg T; Neuhaus R; Müller AR; Hopf U; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13(4):290-6. PubMed ID: 10959482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
